Hyewon Ryu

1.9k total citations
65 papers, 614 citations indexed

About

Hyewon Ryu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hyewon Ryu has authored 65 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Hyewon Ryu's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Hyewon Ryu is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Hyewon Ryu collaborates with scholars based in South Korea, United States and Ethiopia. Hyewon Ryu's co-authors include Hyo Jin Lee, Il Hwan Kim, Baek‐Yeol Ryoo, Kyu‐pyo Kim, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, Ik‐Chan Song, Myoung Joo Kang and Byung Woog Kang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Hyewon Ryu

57 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hyewon Ryu South Korea	16	245	196	146	131	92	65	614
Hyun‐Jeong Shim South Korea	19	329 1.3×	268 1.4×	227 1.6×	202 1.5×	105 1.1×	50	824
Chi Hoon Maeng South Korea	19	258 1.1×	109 0.6×	212 1.5×	164 1.3×	133 1.4×	80	758
Liyan Liu China	14	188 0.8×	93 0.5×	144 1.0×	131 1.0×	75 0.8×	31	660
Anna Zygogianni Greece	15	212 0.9×	151 0.8×	161 1.1×	96 0.7×	60 0.7×	86	722
Olumide B. Gbolahan United States	18	312 1.3×	116 0.6×	179 1.2×	118 0.9×	70 0.8×	65	766
Woo‐Kyun Bae South Korea	16	194 0.8×	183 0.9×	190 1.3×	184 1.4×	53 0.6×	38	627
Kelsey C. Stoltzfus United States	12	360 1.5×	136 0.7×	224 1.5×	86 0.7×	36 0.4×	17	745
Justin Parekh United States	17	173 0.7×	427 2.2×	88 0.6×	145 1.1×	126 1.4×	36	965
Yasir Qazi United States	12	261 1.1×	378 1.9×	95 0.7×	110 0.8×	126 1.4×	34	1.0k
Nandini Menon India	13	256 1.0×	79 0.4×	234 1.6×	103 0.8×	56 0.6×	134	582

Countries citing papers authored by Hyewon Ryu

Since Specialization

Citations

This map shows the geographic impact of Hyewon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyewon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyewon Ryu more than expected).

Fields of papers citing papers by Hyewon Ryu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyewon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyewon Ryu. The network helps show where Hyewon Ryu may publish in the future.

Co-authorship network of co-authors of Hyewon Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Hyewon Ryu. A scholar is included among the top collaborators of Hyewon Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyewon Ryu. Hyewon Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hyung‐Don, Sun Jin Sym, Hong Jae Chon, et al.. (2025). Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab. Journal of Hepatology. 84(2). 308–315. 3 indexed citations

Jeong, Hyehyun, Changhoon Yoo, Il Hwan Kim, et al.. (2025). Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer. JAMA Network Open. 8(10). e2534560–e2534560.

Saborowski, Anna, Jaewon Hyung, Il Hwan Kim, et al.. (2024). 58P Efficacy and safety of liposomal irinotecan (nal-IRI) plus fluorouracil (5-FU) and leucovorin (LV) versus 5-FU/LV alone for advanced biliary tract cancer (BTC) after progression on gemcitabine-based therapy: A pooled analysis of the NIFTY and NALIRICC trials. Annals of Oncology. 35. S235–S235.

Yun, Je‐Yeon, Bhumsuk Keam, Na‐Ri Lee, et al.. (2024). Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients. Scientific Reports. 14(1). 29098–29098.

Yang, Yaewon, Eun Joo Kang, Yu Jung Kim, et al.. (2024). ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).. Journal of Clinical Oncology. 42(16_suppl). 3050–3050. 1 indexed citations

Jang, Yunseon, Jung Yeon Kim, Sang Young Han, et al.. (2024). Establishment of a chronic biliary disease mouse model with cholecystoduodenal anastomosis for intestinal microbiome preservation. World Journal of Gastroenterology. 30(46). 4937–4946.

Kim, Sun Young, Jee Hyun Kim, Tae Yong Kim, et al.. (2024). Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09. BMC Cancer. 24(1). 574–574. 3 indexed citations

Son, Jina, et al.. (2023). Effects of Continuous Nutrition Care on Nutritional Status and Dietary Habits of Patients With Colorectal Cancer Receiving Adjuvant Chemotherapy After Surgery. Clinical Nutrition Research. 12(2). 99–99. 1 indexed citations

Hyung, Jaewon, Il Hwan Kim, Kyu‐pyo Kim, et al.. (2023). Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer. JAMA Oncology. 9(5). 692–692. 42 indexed citations

10.

Kim, In Soo, Sang Yeon Cho, Miso Yang, et al.. (2023). ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma. Anticancer Research. 43(5). 1943–1957. 1 indexed citations

11.

Kim, Sun‐Young, Jee Hyun Kim, Tae Yong Kim, et al.. (2023). Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09).. Journal of Clinical Oncology. 41(16_suppl). TPS1608–TPS1608.

12.

Kang, Sora, Ik‐Chan Song, Hyo Jin Lee, et al.. (2023). Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAFV600E mutation status. Journal of Cancer Research and Clinical Oncology. 149(10). 7819–7829. 3 indexed citations

13.

Ryu, Hyewon, Ik‐Chan Song, Hyo Jin Lee, et al.. (2022). Volumetric Splenomegaly in Patients With Polycythemia Vera. Journal of Korean Medical Science. 37(11). e87–e87. 6 indexed citations

14.

Kwon, Jaeyul, Hyewon Ryu, Hyo Jin Lee, et al.. (2021). Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Hematology. 26(1). 96–102. 6 indexed citations

15.

Song, Ik‐Chan, Hyewon Ryu, Hyo Jin Lee, et al.. (2021). Pulmonary hypertension in patients with chronic myeloid leukemia. Medicine. 100(33). e26975–e26975. 2 indexed citations

16.

Kim, Hwa Jung, Jung Hye Kwon, Sun Kyung Baek, et al.. (2021). The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment. Cancer Research and Treatment. 53(4). 897–907. 16 indexed citations

17.

Ryu, Hyewon, et al.. (2020). A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation. Medicine. 99(34). e21571–e21571. 4 indexed citations

18.

Park, Hye Yoon, Young Ae Kim, Jin-Ah Sim, et al.. (2018). Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act. Journal of Pain and Symptom Management. 57(4). 774–782. 26 indexed citations

19.

Moon, Ji Young, Hyewon Ryu, Ik‐Chan Song, et al.. (2017). Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study. The Korean Journal of Internal Medicine. 33(4). 790–797. 10 indexed citations

20.

Ryu, Hyewon & Hyo Jin Lee. (2014). Beau’s Lines of the Fingernails. The American Journal of the Medical Sciences. 349(4). 363–363. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact